NZ760890B2 - Directional tissue expander - Google Patents
Directional tissue expander Download PDFInfo
- Publication number
- NZ760890B2 NZ760890B2 NZ760890A NZ76089015A NZ760890B2 NZ 760890 B2 NZ760890 B2 NZ 760890B2 NZ 760890 A NZ760890 A NZ 760890A NZ 76089015 A NZ76089015 A NZ 76089015A NZ 760890 B2 NZ760890 B2 NZ 760890B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- reinforcing material
- shell
- implant
- pole region
- face
- Prior art date
Links
- 239000007943 implant Substances 0.000 claims abstract description 59
- 239000012779 reinforcing material Substances 0.000 claims abstract description 55
- 230000002787 reinforcement Effects 0.000 claims abstract description 44
- 239000000463 material Substances 0.000 claims abstract description 23
- 238000002347 injection Methods 0.000 claims abstract description 16
- 239000007924 injection Substances 0.000 claims abstract description 16
- 230000002093 peripheral effect Effects 0.000 claims abstract description 16
- 239000012530 fluid Substances 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 2
- 239000011257 shell material Substances 0.000 description 78
- 210000001519 tissue Anatomy 0.000 description 17
- 229920001296 polysiloxane Polymers 0.000 description 11
- 230000007704 transition Effects 0.000 description 5
- 210000000779 thoracic wall Anatomy 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 229920004934 Dacron® Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- 241001272720 Medialuna californiensis Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/02—Devices for expanding tissue, e.g. skin tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/12—Mammary prostheses and implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0018—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
Abstract
With known mammary tissue expanders, as the inflation process continues, resistive pressure from the tissue on the anterior side of the expander can cause the expander to expand in undesired directions (i.e., axially and laterally). Thus, is would be desirable to provide an expandable mammary implant that better provides for the appropriate directional tissue expansion for any given size. An aspect of the invention includes an expandable mammary tissue implant having a shell having an anterior face and a posterior face having a periphery. The anterior face having an upper pole region and a lower pole region meeting at an apex, and an injection zone for receiving fluid therethrough to inflate the implant. A first reinforcing material having (i) a peripheral rim portion that extends from the periphery of said posterior face and (ii) an upper periphery. The first reinforcement material is coupled to the shell such that the first reinforcing material does not extend along the entire anterior face. A second reinforcing material is coupled to the shell and extends along a portion of the anterior face of the shell. The first reinforcing material abuts or overlaps the second reinforcing material at or adjacent the upper periphery of the first reinforcing material and in at least two locations on opposite sides in the upper pole region thereby forming a hinge point on each of said opposite side of the upper pole region. A portion of the lower pole region is not reinforced by either the first or second reinforcing material. The at least one insert member has at least one cutout or aperture positioned to correspond to or substantially align with the hinge point on each of said opposite side of the upper pole region. The reinforcement zone covers the upper pole and a peripheral zone extending from the peripheral rim of the posterior face into the anterior face such that upon inflation, expansion of the implant occurs disproportionately in the lower pole region. t that better provides for the appropriate directional tissue expansion for any given size. An aspect of the invention includes an expandable mammary tissue implant having a shell having an anterior face and a posterior face having a periphery. The anterior face having an upper pole region and a lower pole region meeting at an apex, and an injection zone for receiving fluid therethrough to inflate the implant. A first reinforcing material having (i) a peripheral rim portion that extends from the periphery of said posterior face and (ii) an upper periphery. The first reinforcement material is coupled to the shell such that the first reinforcing material does not extend along the entire anterior face. A second reinforcing material is coupled to the shell and extends along a portion of the anterior face of the shell. The first reinforcing material abuts or overlaps the second reinforcing material at or adjacent the upper periphery of the first reinforcing material and in at least two locations on opposite sides in the upper pole region thereby forming a hinge point on each of said opposite side of the upper pole region. A portion of the lower pole region is not reinforced by either the first or second reinforcing material. The at least one insert member has at least one cutout or aperture positioned to correspond to or substantially align with the hinge point on each of said opposite side of the upper pole region. The reinforcement zone covers the upper pole and a peripheral zone extending from the peripheral rim of the posterior face into the anterior face such that upon inflation, expansion of the implant occurs disproportionately in the lower pole region.
Description
DIRECTIONAL TISSUE EXPANDER This application is a divisional of New Zealand patent application 724421, which is the national phase entry in New Zealand of PCT international application (published as ), filed 9 March 2015, all of which are incorporated herein by reference.
Field of the Invention The present invention relates generally to the field of expandable implants, and more particularly to expandable mammary implants.
Background Tissue expanders are devices that are implanted beneath the skin and then gradually inflated to stretch the overlying tissue. Such expanders are used to create a pocket for receiving a permanent prosthesis and/or to generate increased skin surface area so that skin can be utilized for grafting or reconstruction.
In the case of mammary implants, tissue expanders are used to create the mammary pocket that will ultimately receive the permanent mammary implant. These expanders are commonly formed of a silicone polymer shell. After implantation, saline or some other fluid is periodically injected into the expander over time, for example through an injection port, until the desired sized pocket is achieved.
With known mammary tissue expanders, as the inflation process continues, resistive pressure from the tissue on the anterior side of the expander can cause the expander to expand in undesired directions (i.e., axially and laterally). In order to minimize the undesired expansion, most surgeons select a smaller expander than needed and overinflate the expander to 200-300 % of the rated volume of the expander. This allows the surgeon to utilize the smaller starting foot print of a smaller expander to accommodate for the undesired axial and lateral expansion. Overinflating a smaller expander is undesirable for various reasons.
Although expanders are technically tested up to twice their nominal inflation volume, 200- 300% inflation could reduce the safety margin of the device. Further, since the footprint is small, at 200-300% inflation the inflated shape is not anatomically correct, but rather is more round or ball-like, which could lead to rotation or flipping over of the implant within the tissue pocket.
Thus, is would be desirable to provide an expandable mammary implant that better provides for the appropriate directional tissue expansion for any given size. It is an object of the present invention to go some way towards meeting this desideratum and/or to at least provide the public with a useful choice.
Summary of the Invention In a first aspect the present invention provides an expandable mammary tissue implant comprising: a shell having an anterior face and a posterior face having a periphery, the anterior face having an upper pole region and a lower pole region meeting at an apex, and an injection zone for receiving fluid therethrough to inflate the implant; a first reinforcing material having (i) a peripheral rim portion that extends from the periphery of said posterior face and (ii) an upper periphery, said first reinforcement material coupled to the shell such that he first reinforcing material does not extend along the entire anterior face; a second reinforcing material coupled to the shell and extending along a portion of the anterior face of the shell; wherein the first reinforcing material abuts or overlaps the second reinforcing material, at or adjacent the upper periphery of the first reinforcing material and in at least two locations on opposite sides in the upper pole region thereby forming a hinge point on each of said opposite side of the upper pole region, and wherein a portion of the lower pole region is not reinforced by either the first or second reinforcing material; the at least one insert member has at least one cutout or aperture positioned to correspond to or substantially align with the hinge point on each of said opposite side of the upper pole region.
Also described is an expandable mammary tissue implant including a shell having an anterior face and a posterior face, with the anterior face having an upper pole portion and a lower pole portion meeting at an apex, and an injection zone for receiving fluid therethrough to inflate the implant. The implant further includes a reinforcing material coupled to the shell in a first reinforcement zone and a second reinforcement zone. The first reinforcement zone forms at least a peripheral rim portion that extends from a periphery of the posterior face upwardly into the anterior face by a predetermined distance, and a first end of the first reinforcement zone is located in the upper pole region of the anterior face. The second reinforcement zone extends from a first end that substantially abuts or overlaps the first end of the first reinforcement zone, and along at least a portion of the anterior face of the shell such that the entire upper pole of the shell is reinforced as between the first and second reinforcement zones.
In one embodiment, the first reinforcement zone further extends along the entire posterior face of the shell. The predetermined distance that the first reinforcement zone extends upwardly into the anterior face of the shell may vary around the periphery of the posterior face of the shell. In yet another embodiment, the second reinforcement zone extends along at least a portion of the anterior face of the shell to an apex of the shell.
The reinforcing material may be a mesh material, and may further be a polyester mesh. The shell may be made of silicone.
In yet another embodiment, the reinforcing material has varying elasticity properties at different locations, and may have an elasticity gradient in a predetermined direction.
According to yet another embodiment, the implant further includes at least one insert member positioned entirely within and extending across an interior of the shell, and coupled to an interior surface of the shell. The insert member may be sized and shaped so as to be coupled to the interior of the shell around an entire perimeter of the insert member, and may further be coupled to the interior of the shell in a location substantially adjacent to an upper periphery of the first reinforcement zone. Alternatively, the insert member may be sized and shaped so as to be coupled to the interior of the shell around a portion of a perimeter of the insert member, and have a cutout therein. The insert member may further include a plurality of apertures therethrough, and/or have an elasticity gradient in a predetermined direction.
According to yet another embodiment, the at least one insert member may be coupled to the interior surface of the shell at first and second ends thereof.
Also described is an expandable mammary implant including a shell having an anterior face and a posterior face, with the anterior having an upper pole portion and a lower pole portion meeting at an apex, and an injection zone for receiving fluid therethrough to inflate the implant. The implant further includes a reinforcement material coupled to the shell in a reinforcement zone. The reinforcement material is coupled to the shell so as to at least coincide with the upper pole portion and a peripheral rim portion that extends from the posterior face upwardly into the anterior face by a predetermined distance.
In another embodiment, the reinforcement zone may further extend from the upper pole portion along the anterior face by a predetermined distance, with the predetermined distance being less than or equal to the distance to the apex of the shell. The reinforcement zone may further coincide with the entire posterior face of the shell. In yet another embodiment, the predetermined distance that the first reinforcement zone extends upwardly into the anterior face of the shell varies around the periphery of the posterior face of the shell.
According to yet further alternate embodiments, the reinforcing material may be a mesh material, such as a polypropylene mesh, and the shell may be made of silicone.
In a further embodiment, the reinforcing material has varying elasticity properties at different locations, and may have an elasticity gradient in a predetermined direction.
An insert member may further be included that is positioned entirely within and extends across an interior of the shell, and is coupled to an interior surface of the shell. It may be sized and shaped so as to be coupled to the interior of the shell around an entire perimeter of the insert member, and may further be coupled to the interior of the shell in a location substantially adjacent to an upper periphery of the first reinforcement zone.
The insert member may further include a plurality of apertures therethrough, and/or have an elasticity gradient in a predetermined direction.
Alternatively, the insert member may be a strip coupled to the interior surface of the shell at first and second ends thereof.
Also described is an expandable mammary tissue implant including a shell having an anterior face and a posterior face, with the anterior face having an upper pole portion and a lower pole portion meeting at an apex, and an injection zone for receiving fluid therethrough to inflate the implant. The implant further includes a reinforcing material coupled to the shell in a reinforcement zone, wherein the reinforcement zone covers the upper pole and a peripheral zone extending from the peripheral rim of the posterior face into the anterior face such that upon inflation, expansion of the implant occurs disproportionately in the lower pole region.
These and other objects, features and advantages of the present invention will be apparent from the following detailed description of illustrative embodiments thereof, which is to be read in connection with the accompanying drawings.
Brief Description of the Drawings Fig. 1 is a cross-sectional side view an exemplary prior art mammary tissue implant; Fig. 2 is a side view of an exemplary mammary tissue implant according to the present invention; Fig. 3 is a perspective view of the device of Fig. 2; Fig. 4a is an exemplary illustration of a possible transition zone between reinforced and non-reinforced portions of a shell; Fig. 4b illustrates the mammary implant of Fig. 3 further including a reinforcing material having varying elastic properties; Figs. 5a-5c illustrate exemplary embodiments of a reinforcing material having varying elastic properties along its length; Fig. 6a is a cross-sectional, perspective view illustrating a mammary tissue implant according to the present invention including an insert member; Fig. 6b illustrates an alternate configuration for a mammary implant having an insert member; Figs. 6c and 6d illustrate the mammary implant of Fig. 3 and further including an insert member; and Figs. 6e-6h illustrate various alternate embodiments of insert members.
Detailed Description Fig. 1 shows a cross-sectional side view of an exemplary prior art mammary tissue expander 4. The expander has a posterior face 10 that lies substantially flat and is placed against a patient’s chest wall, and an anterior face 5 that faces outward from the chest wall when implanted. The anterior face 5 includes an upper pole region 15 (i.e., the upper portion of the shell when the implant recipient is standing), a lower pole region 20 (i.e., the lower portion of the shell when the implant recipient is standing), and an apex 25 (corresponding to the point at which the nipple would be in a natural breast) separating the upper pole region and the lower pole region. The outer shell 35 of the expander 5 is typically made of a silicone material and includes an injection port or other valve or self-sealing zone 40 through which saline or another fluid is injected over time into the contained inner region 30. In this manner, the volume of the expander can be increased over time until the desired size pocket is achieved.
With known expanders such as that shown in Fig. 1, although the overall shape of the expander when fully inflated as shown is somewhat anatomically correct, it has been found that when in use within the body, expansion does not occur in an anatomically correct or desired manner. This is because the expander of Fig. 1 is shown in air, and known expanders are designed and tested in air. Due to the minimal resistance of the surrounding air, an expander with an outer shell comprised of a substantially uniform material will expand to the final shape of that shell. In the body, however, the surrounding tissue and muscles counteract expansion, and a device with a substantially uniform outer shell will expand according to the path of least resistance, often determined by the varying resistance of the surrounding tissue.
For mammary prostheses, this typically results in deformity of the outer shell to a more pancake like shape, with the anterior projection of the lower pole expansion being less than planned or desired, and lateral and axial expansion more than desired. As indicated previously, in an effort to increase the anterior projection of lower pole expansion, surgeons often pick undersized expanders having a smaller footprint (as against the chest wall), and over inflate them.
The present invention overcomes the problems described above and provides for expansion in the appropriate direction in an appropriate sized implant. More specifically, the implants described herein allow for minimized lateral and vertical expansion, while providing a more anatomically correct profile with less fullness in the upper pole region and more fullness and anterior expansion in the lower pole region. As shown in the illustrative embodiment in Fig. 2, the implant described herein includes reinforcement at various locations along the shell to provide for minimal expansion at various desired locations and full expansion at other predetermined locations, to result in an expander that has desired and varied expansion characteristics around its surface area when in actual use within the body.
The expander 100 of Figs. 2 and 3 similarly includes a posterior face 110 and an anterior face 105 that includes an upper pole region 115, a lower pole region 120, and an apex 125. As indicated previously, the posterior face is substantially flat when the shell is inflated and is the portion of the shell that lies against the patient’s chest wall. The posterior face is defined by periphery 141. The expander also includes an injection zone 40. The injection zone may be an injection dome of the well-known type as illustrated in Fig. 1, may be a self-sealing area, or any other suitable device/area through which fluid can be injected and/or removed from the implant.
The outer shell 135 of the expander 100 further includes one or more reinforcement zones, wherein a reinforcing material limits the expandability of the outer shell material.
According to one embodiment, the outer shell is made of silicone, and the reinforcing material is a mesh, such as a polyester mesh, although any suitable implantable mesh may be used. Alternatively, the reinforcing material may be a silicone sheet having an elasticity equal to or lower than the elasticity of the shell. The area of the shell having a reinforcing material coupled to it will have an overall elasticity less than any unreinforced area regardless of the elasticity of the reinforcing material. In a preferred embodiment, however, the reinforcing material has elasticity that is substantially lower than the elasticity of the shell.
Further, any other suitable material may be used that adequately functions to restrict expansion of the shell by having an elasticity that is equal to or less than that of the shell material. Exemplary other materials include silicone based polymers, composite materials, polyurethane, polypropylene, and other biocompatible polymeric materials. The reinforcing material may be coupled to the shell by covering the mesh with an un-vulcanized silicone sheet and pressing it into the shell such that the un-vulcanized silicone sheet essentially acts as a glue. The strength of the formed connection can be improved by curing the silicone at an elevated temperature over a period of time (i.e., 315-350 degrees Fahrenheit for approximately 30 minutes).
The embodiment of Fig. 2 includes a first reinforcement zone 140 and a second reinforcement zone 150, both of which are illustrated with cross-hatching. The first reinforcement zone 140 has a first end 146 and a second end 144, and includes at least a peripheral rim portion 148 that extends from the periphery 141 of the posterior face 110 upward into the anterior face 105 by a predetermined distance to an upper periphery 103.
The predetermined distance may be constant around the periphery, or may vary along the periphery as shown in Fig. 2. The first reinforcement zone may further extend so as to coincide with the entirety of the posterior face, or some portion thereof. The first reinforcement zone 140 restricts lateral and axial expansion of the shell in the peripheral area immediately adjacent to the posterior face. In this manner, the surgeon need not choose an expander having a smaller posterior face than desired in order to account for undesired lateral expansion around the perimeter of the base of the implant.
The embodiment of Fig. 2 further includes a second reinforcement zone 150. A first end 152 of the second reinforcement zone preferably substantially abuts or overlaps a first end 148 of the first reinforcement zone 140 so that the upper pole region 115 of the expander is entirely reinforced as between the first and second reinforcement zones. In this manner, upon being infused with fluid, the expander is unable to appreciably expand in the upper pole region. The second reinforcement zone extends from the first end 152 and along at least a portion of the anterior face region 105 of the expander, essentially forming a reinforced "hinge" like structure centered around the upper pole region 115, and having hinge points 149 on both sides where the first and second reinforcement zones first meet and start to overlap or abut each other. In certain embodiments, the reinforcement material covers from about 25% to about 80% of the shell surface area, and more preferably from about 50% to about 75% of the shell surface area.
In this manner, expansion of the upper pole region beyond the intended shape is restricted, while more freely allowing desirable expansion of the lower pole region 120. In one embodiment, the second reinforcement zone extends substantially to the apex 125 of the shell.
Although the embodiment above is described as having first and second pieces of reinforcing material, one skilled in the art will readily understand that the reinforcement zones can be established with a single piece as well.
In a further aspect described herein, the reinforcing material may be designed so that the degree of elasticity of the material varies at different locations. With a uniform reinforcing material, particularly when the elasticity of the reinforcing material is much different than that of the shell, it may be the case that somewhat sharp transition zones appear between the reinforced regions of the shell and the unreinforced regions. An exemplary illustration is shown in Fig. 4a, wherein the implant shell 400 is reinforced along the posterior face 402 and a peripheral region 404 similar to that described above. The difference in elasticity between the shell material and the reinforced zone may cause a sharp transition at the point 405 where the reinforced shell meets the unreinforced shell as demonstrated in Fig. 4a with an implant shell shown in three stages of inflation. To minimize this possible effect, the reinforcing material may have varying elasticity properties at different locations, or simply have an elasticity gradient (gradually decreasing or increasing elasticity properties) in a given direction. In a preferred embodiment, elasticity of the reinforcing material increases in the direction towards the areas which are free of reinforcing material, or have less reinforcing material, so that the reinforcing material immediately adjacent the non-reinforced areas has the highest elasticity. This can be accomplished by various means including, for example, providing apertures in the reinforcing material that vary in size and/or density along the length of the material. Exemplary embodiments are shown in Figs. 5a-5c, with Fig. 5a illustrating circular apertures of varying diameter 500a along the length of the material, and Figs. 5b and 5c illustrating varying slit-like aperture arrangements 500b, 500c along the length of the material. Further, the thickness of the mesh or other material may vary along the length to achieve this result. In another embodiment, both varying aperture size and/or aperture density (i.e., the number of apertures in a given area) along the length of the material and/or simultaneously varying thickness along the length of the material are contemplated to provide the desired elasticity gradient.
Figure 4b illustrates the implant shell 400 having reinforcing zone 420 with a lower elasticity proximal to the posterior face 402 and a higher elasticity in the peripheral region 404, with elasticity increasing due to higher density of apertures 422 cut in the material 420.
As can be seen from Figure 4b, elasticity is higher closest to the transition point 405 where the reinforced shell meets the unreinforced shell.
In yet another embodiment described herein, the device illustrated in Figs. 2 and 3 may further include an additional, separate reinforcing insert member 600 as illustrated in Figs. 6a and 6b. The insert member is positioned entirely within the interior space 601 of the shell 635. In the illustrated embodiment, the insert member is sized and shaped to span the entire interior or the shell and is secured to the interior surface 607 of the shell around its entire periphery 602, preferably at a location substantially adjacent to the upper periphery 603 of the first reinforcement zone 644. The insert member helps minimize undesired effects at a transition zone of the type described above, and further assists in maintaining the desired shape of the implant during expansion. The insert member may further include holes, apertures or the like 606, as illustrated in Fig. 6b, in order to allow movement of fluid within the shell as it is expanded. In alternate embodiments, the insert member may be in the form more of a "tether" or the like, such as a strip (or multiple strips) extending across the interior of the shell at any desired location, rather than having a configuration that substantially spans the entire interior. The insert member may be formed of any suitable material having an elasticity that is suitable to increase the shell’s resistance to outward expansion, such as TM TM Dacron , polypropylene, Dacron -silicone composite, etc. The insert member may be secured to the inside of the shell using un-vulcanized silicone sheeting and heat, silicone- based adhesives, solvent-based bonding, diffusion bonding, ultrasonic welding, laser-spot welding, and other techniques known to a skilled artisan.
Figs. 6c and 6d illustrate the implant of Fig. 3 having alternate insert member 600 therein. In this embodiment, the insert member (shown in dotted lines in Fig. 6c) is positioned in a substantially similar manner as illustrated in Figs. 6a and 6b, but has an alternate "half-moon" type shape, as shown clearly in Fig. 6d.
The reinforcing insert member 600 may have various other shapes and configurations, examples of which are shown in Figs. 6e-6h. In Fig. 6f, the insert member 600 has a cutout 610 generally shaped/positioned so that its first and second points 650, 651 correspond to or substantially align with the hinges 149 where the first and second reinforcement zones begin to overlap (see Fig. 2). In Fig. 6e, the insert member 600 has a large size aperture 618 which is generally shaped/positioned so as to correspond to the location of the hinges. The size and location of large size aperture 618 are selected to locally increase elasticity of insert member 600, with area of the large size aperture 618 being from about 20% to about 40% of area of insert member 600, most preferably from about 20% to about 30% of area of insert member 600. Fig. 6g illustrates an insert member 600 with at least one optional aperture 606 and an array of slits 614 providing for increased elasticity of the insert member 600. The array 614 is generally shaped/positioned so as to correspond to the location of the hinges.
Finally, Fig. 6h illustrates an insert member 600 having a plurality of apertures 615 providing for increased elasticity of insert member 600, with apertures 615 generally shaped/positioned so as to correspond to location of hinge point as described previously.
Although illustrative embodiments of the present invention have been described herein with reference to the accompanying drawings, it is to be understood that the invention is not limited to those precise embodiments and that various other changes and modifications may be effected herein by one skilled in the art without departing from the scope or spirit of the invention.
The term "comprising" as used in this specification and claims means "consisting at least in part of". When interpreting statements in this specification, and claims which include the term "comprising", it is to be understood that other features that are additional to the features prefaced by this term in each statement or claim may also be present. Related terms such as "comprise" and "comprised" are to be interpreted in similar manner.
In this specification where reference has been made to patent specifications, other external documents, or other sources of information, this is generally for the purpose of providing a context for discussing the features of the invention. Unless specifically stated otherwise, reference to such external documents is not to be construed as an admission that such documents, or such sources of information, in any jurisdiction, are prior art, or form part of the common general knowledge in the art.
In the description in this specification reference may be made to subject matter that is not within the scope of the claims of the current application. That subject matter should be readily identifiable by a person skilled in the art and may assist in putting into practice the invention as defined in the claims of this application.
Claims (7)
1. An expandable mammary tissue implant comprising: a shell having an anterior face and a posterior face having a periphery, the anterior face having an upper pole region and a lower pole region meeting at an apex, and an injection zone for receiving fluid therethrough to inflate the implant; a first reinforcing material having (i) a peripheral rim portion that extends from the periphery of said posterior face and (ii) an upper periphery, said first reinforcement material coupled to the shell such that he first reinforcing material does not extend along the entire anterior face; a second reinforcing material coupled to the shell and extending along a portion of the anterior face of the shell; wherein the first reinforcing material abuts or overlaps the second reinforcing material, at or adjacent the upper periphery of the first reinforcing material and in at least two locations on opposite sides in the upper pole region thereby forming a hinge point on each of said opposite side of the upper pole region, and wherein a portion of the lower pole region is not reinforced by either the first or second reinforcing material; the at least one insert member has at least one cutout or aperture positioned to correspond to or substantially align with the hinge point on each of said opposite side of the upper pole region.
2. The implant according to claim 1, wherein the first reinforcing material further extends within the implant along the entire posterior face of the shell.
3. The implant according to claim 1, further comprising an injection zone in the upper pole region of the anterior face for receiving fluid therethrough to inflate the implant; and a vertical tether member having first and second ends and a central region therebetween having an aperture therethrough, wherein the central region is coupled to the anterior face of the implant at a location such that the injection zone is positioned within the aperture in the central region, and wherein the first and second ends of the vertical tether member are coupled to the posterior face of the implant.
4. The implant according to claim 1, wherein said at least one insert member is a strip coupled at first and second ends thereof in said one or more locations substantially adjacent to the upper periphery of the first reinforcing material.
5. The implant according to claim 1, further comprising an injection zone in the upper pole region of the anterior face for receiving fluid therethrough to inflate the implant; and a vertical tether member having a first and second ends and a central region therebetween having an aperture therethrough, wherein the central region is coupled to the anterior face of the implant at a location such that the injection zone is positioned within the aperture in the central region, and wherein the first and second ends of the vertical tether member are coupled to the posterior face of the implant.
6. The implant according to claim 5, wherein the at least one insert member has at least the first and second apertures therein, and the vertical tether member has a first and second vertical portions on either side between the central region and the respective first and second ends, and wherein the first and second vertical portions extend through said respective first and second apertures of the insert member.
7. An implant as claimed in any one of claims 1-6 substantially as herein described with reference to any example thereof.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/230,251 | 2014-03-31 | ||
US14/230,251 US9700405B2 (en) | 2014-03-31 | 2014-03-31 | Directional tissue expander |
NZ724421A NZ724421B2 (en) | 2014-03-31 | 2015-03-09 | Directional tissue expander |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ760890A NZ760890A (en) | 2021-04-30 |
NZ760890B2 true NZ760890B2 (en) | 2021-08-03 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10617516B2 (en) | Directional tissue expander | |
CA2943836C (en) | Directional tissue expander | |
AU2016229479B2 (en) | Tissue expander with pectoral attachment | |
NZ760890B2 (en) | Directional tissue expander | |
NZ724421B2 (en) | Directional tissue expander |